Publicacións en colaboración con investigadores/as de University of Münster (5)

2023

  1. Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists

    Communications biology, Vol. 6, Núm. 1, pp. 376

2022

  1. Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1361-1368

2021

  1. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7